French scientist behind controversial Covid treatment faces fresh scrutiny over research ethics

A new analysis has cast doubt on the

A new analysis has cast doubt on the scientific integrity of a prominent French researcher whose Covid-19 claims gained international attention, including endorsements from former President Donald Trump and Dr. Mehmet Oz. The study, conducted by an international panel of experts, identified serious ethical and legal red flags in hundreds of research papers tied to the Méditerranée Infection University Hospital Institute (IHU) in Marseille.

According to the review, the team found problematic issues in 853 articles published under the IHU's umbrella—a figure significantly higher than those cited in earlier inquiries into the institution's output. The majority of these flagged papers, 758 in total, list Professor Didier Raoult, the institute's founder, as a co-author. Raoult, a polarizing figure in the medical community, rose to prominence during the pandemic by championing hydroxychloroquine as a treatment for Covid-19, a stance that was amplified by high-profile political figures and media personalities.

The new findings add to a growing body of criticism surrounding Raoult's work, which has already faced multiple internal and external reviews. However, the scale of the concerns raised in this latest analysis is unprecedented, suggesting systemic issues within the IHU's research practices. The researchers behind the review have not yet disclosed the full details of the alleged ethical violations, but they emphasize that the problems are substantial enough to warrant immediate attention from regulatory bodies.

This development is particularly significant given the i…

This development is particularly significant given the influence of Raoult's early pandemic research on public policy and treatment protocols in several countries. His unorthodox methods and rapid publication pace were often at odds with standard scientific protocols, leading to accusations of data manipulation and inadequate peer review. The new analysis underscores these worries, with experts calling for a thorough re-examination of his published work and its impact on global health decisions.

As the scientific community grapples with these revelations, questions are mounting about how such a large volume of potentially compromised research was allowed to circulate for years. The findings also highlight the broader need for stronger oversight in fast-paced research environments, especially those that become focal points during public health emergencies. For now, the focus remains on what these ethical breaches might mean for the credibility of past Covid-19 studies and the lessons that must be learned to prevent similar issues in the future.